Millipore Launches MILLIPLEX™ MAP

Millipore Corporation, a Life Science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, today announced the launch of its MILLIPLEX MAP (multi-analyte profiling) portfolio. For the first time, two industry-leading product lines, Beadlyte^® and LINCOplex^®, are combined in this single, comprehensive kit, presenting the newest and best thinking from the world’s first multiplexing leaders.

MILLIPLEX MAP is the best-quality multiplex kit on the market, displaying the greatest lot-to-lot consistency with uniform analyte profiles irrespective of plex size. To verify this consistency, Millipore provides quality controls with each kit. Millipore’s standards validation process results in consistent standard curves across lots and across analytes. This is especially important for long-term studies. Standard curve ranges are fixed for the analytes in a panel. Consequently, template setup for one analyte can be used with other analytes in the same panel and across different lots, making data analysis much easier.

Multiplexing is faster and more convenient than ever with MILLIPLEX MAP, providing all the reagents needed, including serum matrix, in an all-one-box format. Customers can choose from an analytically validated panel of analytes to create a custom kit, or they can select a pre-mixed kit.

MILLIPLEX MAP offers the broadest selection of analytes across a wide range of therapeutic areas. For the first time, a single catalog number provides the solution to multiplexing needs in oncology, endocrinology, bone metabolism, metabolic syndrome, cell signaling, and more. Complete assay services complement Millipore’s products at every step of research and development. Combining both products and services from the leaders of multiplexing results in faster and better answers. For more information, please view the article webpage.